Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice.

  title={Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice.},
  author={Jacek Jawień and Justyna Totoń-Żurańska and Mariusz Gajda and Anna Niepsuj and Anna Gębska and Katarzyna Kuś and Maciej Suski and Grażyna Pyka-Fościak and Bernadeta Nowak and Tomasz J. Guzik and Jadwiga Marcinkiewicz and Rafał Olszanecki and Ryszard Korbut},
  journal={Journal of physiology and pharmacology : an official journal of the Polish Physiological Society},
  volume={63 1},
Our interest focused on an open question whether AT-(1-7), nonpeptide receptor agonist: AVE 0991, is able to ameliorate atherosclerosis. We used an apolipoprotein E (apoE) - knockout mice model of atherosclerosis. Experimental groups received the same diet as control, mixed with: AVE 0991 at a dose of 0.58 μmol/kg b.w./day, perindopril at a dose of 0.4 mg/kg b.w./day or with tiorphan at a dose of 2.5 mg/kg b.w./day. A-779 [(D-alanine)-angiotensin (1-7)] was given at a dose of 3.3 mg/kg b.w., 3… CONTINUE READING
20 Citations
51 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 20 extracted citations


Publications referenced by this paper.
Showing 1-10 of 51 references


  • atherosclerosis Hansson GK. Inflammation, coronary artery disease. N Engl J Med 2005, 352
  • 83 Fig. 6. (A) Two "counteracting" systems in RAS…
  • 2009
Highly Influential
8 Excerpts

in male apoE ( - / - ) mice

  • GK Hansson, A Hermansson
  • 2011

Similar Papers

Loading similar papers…